AI decodes epilepsy signals in brain waves before seizures appear
June 4, 2026
University of Delaware researchers are using artificial intelligence to detect early warning signs hidden in the brain’s electrical rhythms.
University of Delaware researchers are using artificial intelligence to detect early warning signs hidden in the brain’s electrical rhythms.
A recent study has found a way to track heart rate without requiring people to wear anything at all. Instead, all they need is for someone to use their smartphone, which is quite convenient, since the average person already spends upwards of five hours a day on their phone.
Researchers at the Terasaki Institute for Biomedical Innovation and the University of Arizona College of Medicine have developed a topical gel formulation with 4-aminopyridine (4-AP), to treat burn wounds.
HORW, Switzerland, June 4, 2026 /PRNewswire/ — CeQur®, the company dedicated to simplifying mealtime insulin delivery for people living with diabetes, today announced two recent FDA clearances for CeQur Simplicity™: extended wear of up to seven days and a new 1-unit (1U) device.
Irvine, CA-based OrthAlign has announced FDA 510(k) clearance for the Lantern ASC system, a handheld orthopedic navigation solution designed for ambulatory surgery centers. The system pairs a reusable navigation unit with a procedural Smart Pack Kit to deliver accurate, real-time navigation for total knee, partial knee, and gap balancing procedures in both primary and revision cases.
Lab-grown brains could help scientists reawaken nerve regeneration.
GE HealthCare (Nasdaq:GEHC) announced today that it received FDA 510(k) clearance for its MIM Contour ProtégéAI+ 2.0 software.
The device, created by engineers and cancer scientists led by Professor David Flynn, represents an important step toward next-generation implantable photonic medical technologies
Results of a multicenter clinical trial found that adding the investigational adenoviral-based viral immunotherapy aglatimagene besadenovec (alglatimagene, CAN-2409) to standard radiation therapy improved disease-free survival for patients with intermediate- or high-risk localized prostate cancer.
An international research team led by the A*STAR Genome Institute of Singapore (A*STAR GIS) has developed HERRO, an artificial intelligence (AI) tool that could make it easier and more cost-effective to produce complete, high-quality genome assemblies.